当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Mehmet Serefettin
Currently, gastrointestinal stromal tumors (GIST) have been emphasized considerably in the literature. Following the date of the description of interstitial cells of Cajal (ICC) by Santiago Ramon y Cajal in the late 19th century, this issue has been very popular. Lately, discovery of the association of GISTs with c-Kit mutations in their development, and the significance of drugs such as imatinib, that inhibit c-Kit mutations in their treatment, has increased the interest of researchers. Our aim is to review the nomenclature about ICC and GISTs in the light of literature, to discuss the definition of GIST, which is a heterogeneous, pleomorphic tumor, in its historical progression and in the light of new data, and to suggest the naming these tumors as “tumor of Cajal”, “”Cajal tumor” or “Cajal cell tumor” instead.